Success Metrics

Clinical Success Rate
78.6%

Based on 11 completed trials

Completion Rate
79%(11/14)
Active Trials
1(3%)
Results Posted
9%(1 trials)
Terminated
3(8%)

Phase Distribution

Ph not_applicable
9
23%
Ph phase_3
8
20%
Ph phase_2
4
10%
Ph phase_4
11
28%

Phase Distribution

0

Early Stage

4

Mid Stage

19

Late Stage

Phase Distribution32 total trials
Phase 2Efficacy & side effects
4(12.5%)
Phase 3Large-scale testing
8(25.0%)
Phase 4Post-market surveillance
11(34.4%)
N/ANon-phased studies
9(28.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

73.3%

11 of 15 finished

Non-Completion Rate

26.7%

4 ended early

Currently Active

1

trials recruiting

Total Trials

40

all time

Status Distribution
Active(2)
Completed(11)
Terminated(4)
Other(23)

Detailed Status

unknown22
Completed11
Terminated3
Not yet recruiting1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
40
Active
1
Success Rate
78.6%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (12.5%)
Phase 38 (25.0%)
Phase 411 (34.4%)
N/A9 (28.1%)

Trials by Status

not_yet_recruiting13%
recruiting13%
withdrawn13%
suspended13%
completed1128%
unknown2255%
terminated38%

Recent Activity

Clinical Trials (40)

Showing 20 of 40 trialsScroll for more
NCT06381661Phase 2

Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial

Not Yet Recruiting
NCT06845423Phase 4

Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk

Recruiting
NCT04645550Phase 4

Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT)

Completed
NCT04508855

Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)

Withdrawn
NCT06484634Not Applicable

Role of Low-Molecular-Weight Heparin in Unexplained Recurrent Pregnancy Loss

Completed
NCT04164693Not Applicable

Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula

Completed
NCT03324139Phase 3

Treatment of Intrauterine Growth Restriction With Low Molecular Heparin.

Completed
NCT05604859Phase 4

Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)

Unknown
NCT05878574

Prospective Study of BMD and Ca-P Metabolism in RSA Patients: LMWH Use Versus Control

Unknown
NCT05545475

Safety of Anticoagulant Therapy After Tissue Glue for Gastric Varices

Unknown
NCT04394182Not Applicable

Ultra Low Doses of Therapy With Radiation Applicated to COVID-19

Suspended
NCT05279391Not Applicable

Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19

Unknown
NCT04727437Phase 3

STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism

Unknown
NCT04196309Phase 4

Effect of LOW-molecular-weight Heparin in Reducing Radial Artery Occlusion Rate After Transradial Coronary Catheterization

Completed
NCT04380818Not Applicable

Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19

Unknown
NCT04946929Phase 3

Ticagrelor in Post-transplant Patients With Pediatric Hepatic Artery Thrombosis (HAT)

Unknown
NCT04393805

Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto

Completed
NCT04741295Not Applicable

Low Molecular Weight Heparin on the Adenomyosis Patients'IVF-ET Outcome

Unknown
NCT04450446

Restart Anticoagulation in Patients With Spontaneous Intracerebral Hemorrhage and Mechanical Heart Valves

Unknown
NCT03200613Phase 2

Apixaban For Thromboprophylaxis In Patients With Acute Spinal Cord Injury

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
40